Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1997-11-04
1998-09-29
Criares, Theodore J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
A61K 31155
Patent
active
058146709
ABSTRACT:
The present invention provides a method for treating hypertension in insulin resistant patients comprising the administration of an insulin sensitizing agent, particularly ciglitazone or pioglitazone.
REFERENCES:
patent: 3542927 (1970-11-01), McManus
patent: 4287200 (1981-09-01), Kawamatsu
patent: 4382958 (1983-05-01), Duckworth
patent: 4572912 (1986-02-01), Yoshioka
patent: 4687777 (1987-08-01), Meguro
patent: 5053420 (1991-10-01), Pershadsingh
patent: 5100919 (1992-03-01), Ulrich et al.
patent: 5134164 (1992-07-01), Meglasson
Pereda, et al., Am. J. Physiol., 202(2):249-252 (1962).
Ferrannini, et al., New Engl. J. of Med., 317:350-359 (1987).
Bravo, et al., Am. J. Hypertension, 2(12):339S-344S (1989).
Modan, et al., J. Clin. Invest., 75:809-817 (1985).
Shen, et al., J. Clin. Endocrinology and Metabolism, 66:580-583 (1988).
Zavaroni, et al., New Engl. J. of Med., 320(11):702-706 (1989).
Reaven, et al., Lancet, 2:435-436 (1987).
Krotkiewski, et al., Metabolism, 28(6):650-658 (1979).
Reaven, et al., Hypertension, 12(2):129-132 (1988).
Carretta, et al., Hypertension, 7(6):S196-S197 (1989).
Lucas, et al., Hypertension, 7(5):702-706 (1985).
Manicardi, et al., J. Clin. Endocrinology & Metabolism, 62:1302-1304 (1986).
Reaven, et al., Hypertension, 14(2):117-120 (1989).
Tedde, et al., Am. J. Hypertension, 2:163-170 (1989).
Landsberg, Yale Journal of Biology and Medicine, 62:511-519 (1989).
Rose, et al., Hypertension, 8(9):793-800 (1986).
Berglund, et al., Hypertension, 4(5):692-696 (1982).
MacMahan, et al., Lancet, pp. 1233-1236 (1985).
Sowers, et al., Hypertension, 4:686-691 (1982).
Rocchini, et al., Hypertension, 13(6):922-928 (1989).
Novels, et al., Netherlands J. of Med., 35:295-302 (1989).
Krieger, D.R. and Landsberg, L., Am. J. Hypertension, 1:84-90 (1988).
Connacher, et al., Brit. Med. J., 296:1217-1220 (1988).
Chang, et al., Diabetes, 32:830-838 (1983).
Chang, et al., Diabetes, 32:839-845 (1983).
Pedersen, et al., Diabetic Medicine, 6:249-256 (1989).
Challis, et al., Biochemical and Biophysical Research Comm., 128(2):928-935 (1985).
Rochet, et al., Am. J. Physiol. (Endocrinol. Metab. 18), E101-E109 (1988).
Anderson, et al., Am. J. Gastroenterol., 81:907-919 (1986).
Jimenez, et al., J. Clin. Endocrinol. Metab., 64:661-668 (1987).
Kurtz, et al., Hypertension, 13:896-901 (1989).
Kaplan, et al., Arch. Intern. Med., 149:1514-1520 (1989).
Landsberg, et al., Quarterly J. Medicine, New Series 01. No. 230, 1081-1090, Dec. 1980 (Reference not provided at this time).
Diabetes, vol. 35 Supplement 1, published 1986, p. 66, M.V. Sennitt, et al., Abstract No. 262; and M.A. Cawthorne, et al., Abstract No. 263.
Criares Theodore J.
Pharmacia & Upjohn Company
Welch Lawrence T.
LandOfFree
Use of insulin sensitizing agents to treat hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of insulin sensitizing agents to treat hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of insulin sensitizing agents to treat hypertension will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-686790